Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Recordati
  6. Summary
    REC   IT0003828271

RECORDATI

(REC)
  Report
Delayed Quote. Delayed Borsa Italiana - 11/26 11:36:56 am
54.76 EUR   -2.21%
11/22RECORDATI : Ex-dividend day for interim dividend
FA
11/09Ultima presentazione del gruppo
PU
11/09Latest Company presentation
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Borsa Italiana
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
56.28(c) 55.4(c) 55.58(c) 56(c) 54.76(c) Last
286 612 422 472 170 816 166 571 398 478 Volume
-0.42% -1.56% +0.32% +0.76% -2.21% Change
More quotes
Estimated financial data (e)
Sales 2021 1 577 M 1 785 M 1 785 M
Net income 2021 406 M 460 M 460 M
Net Debt 2021 813 M 920 M 920 M
P/E ratio 2021 28,5x
Yield 2021 2,04%
Sales 2022 1 706 M 1 931 M 1 931 M
Net income 2022 430 M 486 M 486 M
Net Debt 2022 724 M 819 M 819 M
P/E ratio 2022 27,2x
Yield 2022 2,17%
Capitalization 11 245 M 12 725 M 12 727 M
EV / Sales 2021 7,65x
EV / Sales 2022 7,02x
Nbr of Employees 4 446
Free-Float 46,6%
More Financials
Company
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system,... 
Sector
Pharmaceuticals
Calendar
02/24Earnings Release
More about the company
Ratings of Recordati
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about RECORDATI
11/22RECORDATI : Ex-dividend day for interim dividend
FA
11/09Ultima presentazione del gruppo
PU
11/09Latest Company presentation
PU
10/29RECORDATI : Share buy-back program to service the stock option plans
PU
10/28Recordati Expects FY21 Results to Hit Lower End of Guidance Range
MT
10/28RECORDATI : 2021 first nine months results approved. revenue +5.7%, ebitda +2.1% and net i..
PU
10/282021 First nine months results
PU
10/28RECORDATI : 2021 first nine months results approved. revenue +5.7%, ebitda +2.1% and net i..
PU
10/15STOXX EUROPE 600 : Italy's ITA Seeks to Join Airline Pact in 2022
MT
10/15AIR FRANCE KLM : Alitalia successor ITA wants to join a strategic alliance, says chairman
RE
10/11RECORDATI : Resignation of a non-executive director
PU
10/11RECORDATI : 2022 corporate events' calendar
PU
07/30RECORDATI : Public disclosure
PU
07/29Recordati Industria Chimica E Farmaceutica S.P.A. Reports Earnings Results for the Half..
CI
07/29Recordati Revises Revenue Guidance for the Full Year of 2021
CI
More news
News in other languages on RECORDATI
11/26ITA : Zingaretti; Governo intervenga, serve progetto solido
11/26TIM : kkr studia offerta congiunta con Cvc per Opa (Stampa)
11/24RECORDATI : tra 15 al 19/11 acquistate 128.186 azioni proprie
11/22BORSA : commento di chiusura
11/22BORSA : avvio prudente per le piazze europee
More news
Analyst Recommendations on RECORDATI
More recommendations
Chart RECORDATI
Duration : Period :
Recordati Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECORDATI
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 54,76 €
Average target price 49,48 €
Spread / Average Target -9,64%
EPS Revisions
Managers and Directors
Andrea Recordati Chief Executive Officer
Luigi Felice la Corte Group Chief Financial Officer
Alfredo Altavilla Chairman
Raffaele Sabia Senior VP-Pharmaceutical Research & Development
Michaela Castelli Lead Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RECORDATI20.80%12 725
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049